New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 27, 2012
09:13 EDTVRTXVertex anti-flu treatment could interest investors, says Wells Fargo
Wells Fargo believes that investors are currently giving Vertex's flu treatment little or no value, but the firm thinks preclinical data indicates that the drug may be effective and have advantages over Tamiflu. The firm believes that investors may become interested in the long-term revenue potential of the drug, and it maintains an Outperform rating on the stock.
News For VRTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 30, 2015
07:59 EDTVRTXVertex price target raised to $150 from $131 at Leerink
Subscribe for More Information
April 29, 2015
17:49 EDTVRTXVertex CEO says Orkambi currently under review by the FDA
Subscribe for More Information
16:04 EDTVRTXVertex sees FY15 Kalydeco revenue $560M-$580M
Sees FY15 combined non-GAAP R&D and SG&A expenses will be in the range of $1.05B-$1.10B.
16:02 EDTVRTXVertex reports Q1 EPS (62c), consensus (75c)
Reports Q1 revenue $138.51M, consensus $142.38M.
15:00 EDTVRTXNotable companies reporting after market close
Subscribe for More Information
April 21, 2015
13:34 EDTVRTXGilead paying premium to buy Vertex not warranted right now, says Maxim
After Bernstein suggested in a note to investors earlier that Gilead (GILD) should buy Vertex (VRTX), Maxim responded in its own note that it does not believe paying a premium to buy Vertex makes sense before the company has data showing efficacy for Kalydeco in heterozygotes. Maxim keeps a Hold rating and $121 price target on Vertex shares.
12:33 EDTVRTXOn The Fly: Top stock stories at midday
Subscribe for More Information
12:21 EDTVRTXVertex rises after Bernstein suggests Gilead should pursue takeover
Subscribe for More Information
08:14 EDTVRTXGilead should buy Vertex, says Bernstein
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use